Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
NeuroGyn Norr AB
AB
Active
Org 5566708284
Segelvägen 8, 914 31
Nordmaling
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2004
1 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
NeuroGyn Norr AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
1M
2M
2M
2M
2020
2M
2021
1M
2022
1M
2023
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
2 117
1 945
1 457
682
683
Staff expenses
—
—
−899
−307
−211
EBITDA
639
212
−217
−184
3
Depreciation & amort.
−3
−5
−8
−5
−4
EBIT
636
207
−225
−189
−0
Net financials
123
−266
−116
−141
−10
Profit before tax
649
68
−231
−330
−11
Tax
−76
−82
—
—
−5
Net profit
573
−14
−231
−330
−16
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
1 620
1 333
984
662
1 185
Equity
888
574
243
163
147
Long-term debt
0
0
—
—
—
Short-term debt
622
649
741
499
1 038
Total debt
622
649
741
499
1 038
Financial ratios
5-year trend
EBITDA-margin
0.5%
This company
15.8%
Market median
-97% vs market
2020
2024
Soliditetsgrad
12.4%
This company
38.2%
Market median
-68% vs market
2020
2024
Egenkapitalforrentning
-10.7%
This company
18.4%
Market median
-158% vs market
2020
2024
Nettoresultatgrad
-2.3%
This company
8.1%
Market median
-128% vs market
2020
2024
Aktivomsætning
0.58×
This company
1.12×
Market median
-48% vs market
2020
2024
Gæld/egenkapital
7.06×
This company
0.62×
Market median
-1039% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on NeuroGyn Norr AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
